The eMap-Coronavirus2019

EU PUBLIC HEALTH

Last update Date/Time:

With the epidemic outbreak caused by the new coronavirus, the EU has gradually made a series of decisions in all areas of its competence and which can support member countries and the world community in their battle to defeat the new virus and to provide valid remedies for the consequences in the health, social and economic fields.

​This Interactive Neural eMap offers an updated mapping of new and ongoing EU Initiatives for Public Health measures for fighting the new Coronavirus.

 

Outline show/hide

PUBLIC HEALTH

SUPPLIES AND EQUIPMENT

IMPORTS

• 3 April 2020
  Imports, EU Standards and Temporarily lifting customs duties and VAT on imports

  • BRIEFING

EXPORT

• 19 March 2020
  Exports to third Countries only with authorisation & free inside EU

  • BRIEFING

PRODUCTION

• March 2020
  Increasing European production capacities

  • List of available Standards
  • BRIEFING

PUBLIC PROCUREMENT

• 1 April 2020
  . EU Guidance on how to use flexibilities offered by the EU public procurement framework

  • BRIEFING

• Large-scale joint procurement of medical equipment with cooperating nations

  • BRIEFING

SOLIDARITY

• 8 April 2020
  Availability of medicines

  • EU Commission Guidlines

• 2 April 2020
  EU Solidarity for Health Initiative

  • BRIEFING
  • Press Release

• Emergency Support Instrument

  • BRIEFING

• 19 March 2020
  RescEU Stockpile for Medical Devices

  Creation of a Common Strategic Reserve for the stockpiling of medical equipment such as ventilators, protective masks and essential medical gear to help EU countries in need

  • BRIEFING

• Coronavirus Response Investment Initiative

  • BRIEFING

CROSS-BORDER COOPERATION

• Emergency Response Coordination Centre

  • Coordinated by the Health Security Committee

• 2 April 2020

  EU Commission Guidelines

VACCINES STRATEGY

17 June 2020

EU Commission presented a European strategy to accelerate the development, manufacturing and deployment of vaccines against COVID-19

• The EU Commission’s Strategy

• August 2020
  European Commission agreement with pharmaceutical Companies

  • Companies with a promising vaccine candidate, already in or close to starting clinical trials, are invited to contact the Commission at: 

    [email protected]

  • 27 August 2020
    AstraZeneca (SV, UK)

    • BRIEFING

  • 24 August 2020
    Moderna (US)

    • BRIEFING

  • 18 August 2020
    CureVac

    • BRIEFING

  • 13 August 2020
    Johnson & Johnson (US)

    • BRIEFING

  • 13 August 2020
    Sanofi-GSK (F, UK)

    • BRIEFING

  • 21 August 2020
    The Commission decided to register the European Citizens’ Initiative titled ‘Right to Cure’. The aim of this public initiative is to ask that anti-pandemic vaccines and treatments be freely accessible to everyone.

TREATMENT

Plasma

• EU Guidance
• Go to EU CCP Database
• Go to European Blood Alliance
• Go to European Centre for Disease Prevention and Control
• INFO

TEAMS OF EXPERTS

30 March 2020

Recommendations on health systems resilience

17 March 2020

Setting up of the Advisory Panel on COVID-19

18 March 2020

Recommendations for testing strategies

18 March 2020

Recommendations for community measures

CRISIS COORDINATION

Meetings of the Health Security Committee (updated)

Health Security Committee members

Early Warning and Response System (EWRS)

FACTSHEET

PROCESSING OF PERSONAL DATA TO PROTECT PUBLIC HEALTH

19 March 2020

Processing of personal data in the context of the COVID-19 outbreak in relation with exit strategies

• BRIEFING
• Recommendation on apps for contact tracing

RISK ASSESSMENT

European Centre for Disease Prevention and Control

• DATA on worldwide Coronavirus spread
  (constantly updated)

• News & Publications
  (constantly updated)

Rapid risk assessments

Questions & Answers

Practical information to stay healthy, protect ourselves and those around us.

CURRENT EU LEGISLATION

• Council Directive 90/385/EEC on Active Implantable Medical Devices (AIMDD) (1990)
• Council Directive 93/42/EEC on Medical Devices (MDD) (1993)
• Directive 98/79/EC on in vitro Diagnostic Medical Devices (IVDMD)
• Guidelines on COVID-19 in vitro diagnostic tests and their performance 2020/C 122 I/0

List of available Standards

GO TO THE MAIN PAGE

Last update:

​Latest news